Invesco Ltd. Mersana Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 55,483 shares of MRSN stock, worth $33,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,483

Previous 45,056 23.14%

Holding current value

$33,844

Previous $90,000 15.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.23 - $2.25 $12,825 - $23,460	10,427 Added 23.14%	55,483 $104,000
Q2 2024 Aug 13, 2024	SELL	$2.0 - $4.45 $558,708 - $1.24 Million	-279,354 Reduced 86.11%	45,056 $90,000
Q1 2024 May 14, 2024	BUY	$2.16 - $5.94 $595,468 - $1.64 Million	275,680 Added 565.73%	324,410 $1.45 Million
Q4 2023 Feb 12, 2024	SELL	$1.11 - $2.34 $18,095 - $38,146	-16,302 Reduced 25.07%	48,730 $113,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $3.91 $28,000 - $103,286	26,416 Added 68.41%	65,032 $82,000
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $17,879 - $55,437	5,805 Added 17.69%	38,616 $127,000
Q1 2023 May 12, 2023	SELL	$4.0 - $7.02 $1,848 - $3,243	-462 Reduced 1.39%	32,811 $134,000
Q4 2022 Feb 13, 2023	SELL	$5.65 - $7.86 $2.98 Million - $4.15 Million	-528,001 Reduced 94.07%	33,273 $194,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $2.46 Million - $4.26 Million	532,084 Added 1822.83%	561,274 $3.8 Million
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $2,493 - $4,390	-878 Reduced 2.92%	29,190 $135,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $1,309 - $2,320	350 Added 1.18%	30,068 $120,000
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $13,661 - $24,580	-2,493 Reduced 7.74%	29,718 $185,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $44,220 - $74,752	5,166 Added 19.1%	32,211 $303,000
Q2 2021 Aug 17, 2021	SELL	$13.28 - $18.07 $5.11 Million - $6.96 Million	-385,125 Reduced 93.44%	27,045 $368,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $14.1 Million - $24.4 Million	-918,419 Reduced 69.02%	412,170 $6.67 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $3.59 Million - $5.88 Million	213,173 Added 19.08%	1,330,589 $35.4 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $2.18 Million - $3.46 Million	134,621 Added 13.7%	1,117,416 $20.8 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $5.15 Million - $23 Million	982,795 New	982,795 $23 Million

Others Institutions Holding MRSN

# of Institutions

125

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $59.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account